AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.
In this film, AtheroNova C.E.O. Thomas W. Gardner speaks about the market size for atherosclerosis:
//
